sanuwave.com - SNWV Company Value to Revenue Ratio

Public company logo of SANUWAVE (SNWV)

The EV/Sales market multiple reflects the valuation dynamics of Sanuwave Health Inc (SNWV), where 651.23 is the current value of the metric. A cohesive group of acoustic engineers and the strategic hiring of clinical experts support the company. The development of tissue regeneration systems and the expansion of the hospital network mitigate regulatory risks. The environmental strategy is implemented through the creation of durable equipment that reduces the volume of medical waste.

SNWV Sanuwave Health Inc: EV/Sales Multiple in the range 11/23/2025 - 11/20/2026

SNWV (SANUWAVE Health, Inc.): analytical breakdowns and indicator data

- money and cash flow information:
Fundamental valuation:Sanuwave Health Inc SNWV
Mass-produced product of SANUWAVE Health

Sanuwave Health Inc (SNWV) is currently focusing on the organic expansion of sales for its existing medical devices. The price action of the EV/Sales multiple reflects the effectiveness of this strategy by combining market capitalization and net debt relative to each unit of revenue. This metric eliminates the influence of the financing structure, revealing the actual value of the business. A decline in this indicator confirms the asset is undervalued amid growing sales, while high values signal a risk of overpayment.

Competitor analysis for Sanuwave Health Inc

Enterprise Value-to-Revenue Multiple DexCom, Inc.|PEN: EV/Sales Multiple|Company Value to Revenue Ratio NOVT|HAE (Haemonetics Company) - EV/Sales Multiple|Inspire Sleep (INSP) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple PRCT|Company Value to Revenue CONMED Corporation CNMD|EV/Sales Multiple PLSE (pulsebiosciences.com)|EV/Sales Multiple InMode Ltd INMD|PMI: Company Value to Revenue|SRDX: Enterprise Value-to-Revenue Ratio|SENS (Senseonics Corp) - Company Value to Revenue|NeuroPace, Inc. - Business Value to Revenue|TCMD (Tactile Systems Technology, Inc.) - EV/Sales Multiple|EV/Sales Multiple Outset Medical|Enterprise Value-to-Revenue Ratio Electromed (ELMD)|LENSAR, Inc. (LNSR) - Enterprise Value-to-Sales Ratio|AVITA Medical Inc - Company Value to Revenue|EV/Sales Multiple Profound Medical Corporation PROF|Baird Medical Investment Holdings - EV/Sales Multiple|Total Company Value-to-Revenue Ratio EDAP TMS EDAP|Apyx Medical Corporation (APYX) - Enterprise Value-to-Revenue Ratio|Enterprise Value to Sales Volume ICCM (IceCure Medical, Ltd.)|Enterprise Value-to-Revenue Ratio pulmonx.com|Company Value to Revenue TELA Bio, Inc. (TELA)|EV/Sales Multiple CTSO|SRTS - Enterprise Value-to-Revenue Multiple|Enterprise Value-to-Revenue Ratio Zynex, Inc. ZYXI|ECOR: Company Value to Revenue Ratio|RBOT: Company Value to Revenue|inspira-technologies.com - Enterprise Value-to-Revenue Coefficient|ICU: EV/Sales Multiple|IRIX - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Intelligent Bio Solutions Inc.|Enterprise Value-to-Revenue Multiple Beyond Air XAIR|Enterprise Value-to-Revenue Ratio Profusa Inc. (PFSA)|SSKN (STRATA Skin Sciences, Inc.) - Business Value to Revenue|EV/Sales Multiple GCTK (GlucoTrack Inc.)|NanoVibronix, Inc. (NAOV) - Enterprise Value-to-Revenue Multiple|VERO - Enterprise Value-to-Revenue Ratio|NUWE: Enterprise Value-to-Revenue Ratio|Aethlon Medical Inc (AEMD) - Enterprise Value-to-Revenue Ratio|TransEnterix (ASXC) - EV/Sales Multiple|Enterprise Value-to-Revenue Ratio Avinger|BSGM: Business Value to Revenue|EV/Sales Multiple CUTR|Total Company Value-to-Revenue Ratio Know Labs, Inc.|EV/Sales Multiple NARI (Inari Medical)|Business Value to Revenue NVRO|ReShape Lifesciences, Inc. - EV/Sales Multiple|Business Value to Revenue SILK (Silk Road Medical, Inc.)